CNBC Street Signs July 14, 2024
First half net profit jump for roche as they lift their Sales Outlook for the year the ceo tells cnbc the trend will continue into 2020. Given the strong momentum we have with the new medicines, we also expect growth beyond the current year and to be able to continue to overcompensate the effect of the entry of the bio similars. Astrazeneca shares hit a record high as they beat Second Quarter estimates. The ceo hales strong growth in cancer drug sales. It was a growth rate of 19 this was driven by oncology Franchise Growth of 58 . We got to 4 billion for the first half, china grew by 35 . So v...